Sean A. McCarthy - CEO, Director at CytomX Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: CEO, Director
Issuer Symbol: CTMX on Nasdaq
All Insider Reports: All Insider Reports

Sean A. McCarthy - trading volume in the past year for CytomX Therapeutics, Inc.

	Shares	%	Avg Price	Total $
Buys
Sells	-194,960	100%	$3.25	-$633,726
Net	-194,960	-100%		-$633,726

Holdings reported by Sean A. McCarthy for CytomX Therapeutics, Inc.

Security	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	1,197,891	$5,103,015	$4.26	02 Feb 2026	Direct
Class A Common Stock	987,891	$4,482,752	$4.54	06 Nov 2025	Direct
Common Stock	93,158	$396,853	$4.26	02 Feb 2026	Indirect
Performance Stock Units (PSUs)	285,000	$0	$1.23	26 Sep 2025	Direct	Common Stock
Stock Option (Right to Buy)	980,000			02 Feb 2026	Direct	Common Stock
Class A Common Stock	93,158			06 Nov 2025	Indirect
Performance Stock Units	0			13 Jun 2025	Direct	Common Stock

Transactions reported by Sean A. McCarthy for CytomX Therapeutics, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.